Richard J. Smeyne

Richard J. Smeyne serves as Professor and Chair of the Department of Neuroscience at Thomas Jefferson University, concurrently directing the Jefferson Comprehensive Parkinson’s Center within the Vickie and Jack Farber Institute for Neuroscience. His work centers on the cell biology of Parkinson's disease and neurodegenerative mechanisms.

Dr. Smeyne's research investigates environmental and genetic interactions in Parkinson's pathogenesis, focusing on alpha-synuclein aggregation, neuroinflammation, and dopaminergic neuron death. His laboratory employs genetic mouse models, rotenone exposure systems, and neuroanatomical analyses to explore pathways like GUCY2C signaling and microglial regulation of autophagy. Key interests include SARS-CoV-2 neuropathology links, protein misfolding dynamics, and behavioral impacts of social isolation on neural systems.

His publication trends reveal strong emphasis on molecular Parkinson's disease mechanisms, integrating toxicology, immunology, and cell biology. Recent work highlights alpha-synuclein templating effects, neuroprotective signaling cascades, and microglial roles in protein clearance, demonstrating consistent translational focus on therapeutic targets for neurodegeneration.

While student mentorship details are unreported, his dual leadership roles as department chair and center director imply oversight of graduate researchers and substantial grant-funded projects. Dr. Smeyne maintains an active laboratory investigating Parkinson's disease pathogenesis through interdisciplinary approaches.

He leads the Jefferson Comprehensive Parkinson’s Center research team, which examines environmental-genetic interplay in neurodegeneration. Current projects address inflammation triggers, dopamine neuron vulnerability, and autophagy dysregulation, utilizing advanced models to identify disease-modifying interventions.